140 results
8-K
EX-99.1
IDXG
Interpace Biosciences, Inc.
12 Mar 24
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results
7:42pm
Research and development
General and administrative
Acquisition amortization expense
Change in fair value of contingent consideration
Total operating
8-K
EX-99.1
IDXG
Interpace Biosciences, Inc.
8 Nov 23
Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results
5:14pm
September 30,
Revenue, net
Cost of revenue
Gross Profit
Sales and marketing
Research and development
General and administrative
Acquisition amortization
8-K
EX-99.1
rzzpf0
9 Aug 23
Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results
3:47pm
8-K
EX-10.1
5e1aihmy
1 Aug 23
Departure of Directors or Certain Officers
8:59pm
8-K
EX-99.1
tpzxbf
12 May 23
Interpace Biosciences Announces Record First Quarter 2023 Financial and Business Results
4:34pm
8-K
EX-99.1
l9cg u0q7umev
14 Nov 22
Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results
4:52pm
8-K
EX-99.2
mr3pyfr8
7 Sep 22
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-99.1
vxf6 k0n4804bnrl
15 Aug 22
Interpace Biosciences Announces Second Quarter 2022 Financial and Business Results
5:42pm